KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $320.0 million.

  • Bristol Myers Squibb's Capital Expenditures fell 123.46% to $320.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 991.67%. This contributed to the annual value of $1.2 billion for FY2024, which is 322.58% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Capital Expenditures of $320.0 million as of Q3 2025, which was down 123.46% from $361.0 million recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Capital Expenditures registered a high of $378.0 million during Q4 2024, and its lowest value of $173.0 million during Q1 2021.
  • Its 5-year average for Capital Expenditures is $288.9 million, with a median of $278.0 million in 2023.
  • Per our database at Business Quant, Bristol Myers Squibb's Capital Expenditures surged by 7647.06% in 2021 and then crashed by 851.85% in 2022.
  • Over the past 5 years, Bristol Myers Squibb's Capital Expenditures (Quarter) stood at $320.0 million in 2021, then grew by 8.12% to $346.0 million in 2022, then fell by 4.62% to $330.0 million in 2023, then rose by 14.55% to $378.0 million in 2024, then fell by 15.34% to $320.0 million in 2025.
  • Its last three reported values are $320.0 million in Q3 2025, $361.0 million for Q2 2025, and $260.0 million during Q1 2025.